These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Crystal commemorative marking a licensing and commercialization agreement between Corbus Pharmaceuticals and CSPC Pharmaceutical Group. The agreement centers on a potential treatment for tumors associated with lung, breast, and prostate cancers. (23AZH089)
Ark-themed crystal deal toy marking the acquisition by CVS of Signify Health. The home healthcare services company is headquartered in Dallas. (23AKL198)
Crystal deal tombstone marking a follow-on offering by life sciences company Intelligent Bio Solutions The design incorporates the firm’s drug screening cartridge. (23AJH030)
Crystal financial tombstone marking a private placement by Midatech Pharma. The drug delivery technology firm is based in the UK. (23AJH028)
Crystal financial tombstone celebrating Series A funding for Lokavant. Based in New York, Lokavant provides a centralized data repository for clinical drug trials. (23AKL083)
Pill bottle-themed Lucite tombstone marking the acquisition of a royalty interest in worldwide sales of Xenpozyme. Xenpozyme has been developed and approved as a treatment for acid sphingomyelinase deficiency (ASMD). (22AKL627)
Crystal deal toy, incorporating a 3D etching of a DNA strand, commemorating the merger of biotech companies Atrin Pharmaceuticals and Aprea Therapeutics. (22ALJ234)
Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields
